2013
DOI: 10.1038/modpathol.2012.124
|View full text |Cite
|
Sign up to set email alerts
|

Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
33
0
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(39 citation statements)
references
References 57 publications
4
33
0
2
Order By: Relevance
“…Patients with diffuse disease showed marked resistance to treatments, with only one case of complete remission after allogeneic hematopoietic stem cell transplantation. Other researchers reported similar cases as "mycosis fungoides expressing TFH-cell markers" (12,13). We believe that our case fits into this category, although our case showed epidermotropism (Fig.…”
Section: Discussionsupporting
confidence: 67%
See 1 more Smart Citation
“…Patients with diffuse disease showed marked resistance to treatments, with only one case of complete remission after allogeneic hematopoietic stem cell transplantation. Other researchers reported similar cases as "mycosis fungoides expressing TFH-cell markers" (12,13). We believe that our case fits into this category, although our case showed epidermotropism (Fig.…”
Section: Discussionsupporting
confidence: 67%
“…"Primary cutaneous ATIL" has not been proposed as a new entity, therefore we have to include this case in PTCL, NOS. However, several cases with "primary cutaneous TFH-cell lymphoma" or "mycosis fungoides expressing TFH-cell markers" have been reported recently (11)(12)(13). Immunohistochemical study has suggested that our case should fit into this category.…”
mentioning
confidence: 65%
“…According to recent publications, the absence of a significant expression of PD1 and CXCL13 in MF was expected. 27,28 Finally, in our opinion, the B-cell component observed in the skin of our patients being more the result of a homing process than a true cutaneous localization of the B-cell malignant disease, our cases should much more be considered as discordant cutaneous lymphomas than as composite lymphomas. To conclude, both folliculotropic MF and pseudo-folliculotropic MF may occur in patients with small B-cell lymphoproliferations, especially B-CLL.…”
Section: Discussionmentioning
confidence: 79%
“…It is controversial if PD-1 expression itself changes with evolution of disease. CD10 was detected on 10–40% of CD4+ T-cells in MF, using flow cytometry on skin and blood specimens 22 . CXCL-13 may be more commonly found in Sezary patients.…”
Section: Immunophenotypic Variantsmentioning
confidence: 99%